Skip to main content

Advertisement

SpringerLink
Log in

Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells

  • Brief Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

It is now well accepted that tumor cells actively communicate with the tumor microenvironment (e.g., adipocytes) leading to the progression of breast cancer and other malignancies. It is also known that adipose mesenchymal stem cells (MSCs) have the ability to differentiate into mature adipocytes and initiate cytokine signaling within the tumor microenvironment. Here, we examine the role of MSC-differentiated adipocytes on breast cancer cell migration, and test the effects of sulforaphane (SFN, a dietary chemoprevention agent) on adipocyte–breast cancer cell interaction. Our results demonstrate that SFN promotes MSC self-renewal and inhibits adipogenic differentiation. Subsequently, SFN treatment of adipocytes considerably hinders cytokine communication with breast cancer cells, thereby decreasing breast cancer cell migration and tumor formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Galic S, Oakhill JS, Steinberg GR (2010) Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316:129–139

    Article  PubMed  CAS  Google Scholar 

  2. Cristancho AG, Lazar MA (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12:722–734

    Article  PubMed  CAS  Google Scholar 

  3. Kolf CM, Cho E, Tuan RS (2009) Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthr res ther 9:204

    Article  Google Scholar 

  4. Sul HS (2009) Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 23:1717–1725

    Article  PubMed  CAS  Google Scholar 

  5. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, Feng D, Zhuo D, Stoeckert CJ Jr, Liu XS et al (2008) PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22:2941–2952

    Article  PubMed  CAS  Google Scholar 

  6. Yeh WC, Cao Z, Classon M, McKnight SL (1995) Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9:168–181

    Article  PubMed  CAS  Google Scholar 

  7. Wang Y, Sul HS (2009) Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab 9:287–302

    Article  PubMed  CAS  Google Scholar 

  8. Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP et al (2009) Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22:6408–6423

    Article  Google Scholar 

  9. Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S et al (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71:2455–2465

    Article  PubMed  CAS  Google Scholar 

  10. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C (2001) Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276:32008–32015

    Article  PubMed  CAS  Google Scholar 

  11. Gamet-Payrastre L (2006) Signaling pathways and intracellular targets of sulforaphane mediating cell cycle arrest and apoptosis. Curr Cancer Drug Targets 6:135–145

    Article  PubMed  CAS  Google Scholar 

  12. Lee JH, Moon MH, Jeong JK, Park YG, Lee YJ, Seol JW, Park SY (2012) Sulforaphane induced adipolysis via hormone sensitive lipase activation, regulated by AMPK signaling pathway. Biochem Biophys Res Commun 426:492–497

    Article  PubMed  CAS  Google Scholar 

  13. Boquest AC, Shahdadfar A, Frønsdal K, Sigurjonsson O, Tunheim SH, Collas P, Brinchmann JE (2005) Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 16:1131–1141

    Article  PubMed  CAS  Google Scholar 

  14. Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q (2013) Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene. doi:10.1038/onc.2013.226 Epub ahead of print

    Google Scholar 

  15. Castells M, Thibault B, Delord JP, Couderc B (2012) Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. Int J Mol Sci 13:9545–9571

    Article  PubMed  CAS  Google Scholar 

  16. Bochet L, Meulle A, Imbert S, Salles B, Valet P, Muller C (2011) Cancer-associated adipocytes promotes breast tumor radioresistance. Biochem Biophys Res Commun 411:102–106

    Article  PubMed  CAS  Google Scholar 

  17. Bechara C, Chai H, Lin PH, Yao Q, Chen C (2007) Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med sci monit: Int Med J Exp Clin Res 13:RA87–RA90

    CAS  Google Scholar 

  18. Zhu Q, Han X, Peng J, Qin H, Wang Y (2012) The role of CXC chemokines and their receptors in the progression and treatment of tumors. J Mol Histol 43:699–713

    Article  PubMed  CAS  Google Scholar 

  19. Deshmane SL, Kremlev S, Amini S, Sawaya BE (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interf Cytokine Res 29:313–326

    Article  CAS  Google Scholar 

  20. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878–888

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by ACS (Q.Z.), NIH/NCI R01 (Q.Z.), and NIH (P30DK072488, D.W.G). The authors thank Carlo Mercado for help.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA

    Qinglin Li, Jixiang Xia, Yuan Yao & Qun Zhou

  2. Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    Da-wei Gong

  3. Division of Nutrition Science, Nanjing University of Chinese Medicine, Nanjing, China

    Hongfei Shi

Authors
  1. Qinglin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jixiang Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuan Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Da-wei Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hongfei Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qun Zhou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Q., Xia, J., Yao, Y. et al. Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells. Breast Cancer Res Treat 141, 317–324 (2013). https://doi.org/10.1007/s10549-013-2672-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2672-1

Keywords

Search

Navigation